Purchase this report

Secondary Progressive Multiple Sclerosis (SPMS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

Published	Pages	Publisher	Report code
May 2022	68	Global Markets Direct	ASDR-600285

Published: May 2022 - Pages : 68 - Publisher : Global Markets Direct - Report code : ASDR-600285

Secondary Progressive Multiple Sclerosis (SPMS) (Central Nervous System) - Drugs in Development, 2021 Published: April, 2021 - Pages: 75
Global Multiple Sclerosis Partnering 2014 to 2019 Published: March, 2019 - Pages: 150
Global Multiple Sclerosis (MS) Market - Analysis By Drug Class, Route of Administration, Distribution Channel, By Region... Published: December, 2021 - Pages: 220
Autoimmune Disease Diagnostics Market Size, Competitive Market Share & Forecast, 2022 - 2030 Published: July, 2022 - Pages: 190
Autoinjectors Market & Global Forecast, 2023 - 2032 Published: March, 2023 - Pages: 175
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2019 Published: February, 2020 - Pages: 106
Secondary Progressive Multiple Sclerosis (SPMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 Published: January, 2020 - Pages: 60
Multiple Sclerosis - Pipeline Review, H1 2020 Published: June, 2020 - Pages: 1114
Multiple Sclerosis Therapeutics Market Forecast to 2027 Published: February, 2021 - Pages: 169
Primary Progressive Multiple Sclerosis (PPMS) (Central Nervous System) - Drugs in Development, 2021 Published: April, 2021 - Pages: 55